Karine Breckpot
  • Laarbeeklaan 103

    1090 Brussels


  • Source: Scopus
  • Calculated based on number of publications stored in Pure and citations from Scopus
1970 …2024

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Design of innovative immunotherapy strategies. The strategies under development include ex vivo and in vivo engineering of (1) dendritic cells for immune activation and (2) T-cells for cancer cell rejection, and (3) engineering of the tumor microenvironment to facilitate antitumor immune responses. Technologies such as mRNA, lentiviral vectors and single domain antibodies (better known as nanobodies) are employed for these purposes. Strategies under development are extensively tested in preclinical in vitro models using cells of human and mouse origin as well as in mouse cancer models. Successful strategies are translated towards clinical applications in phase I/II trials.

Research interests

Cancer immunology and immunotherapy:

- Cancer vaccination

- T-cell therapy

- Immune checkpoint therapy

Education/Academic qualification

Education, Educational Professionalisation Pathway for Teaching Staff, Vrije Universiteit Brussel

Award Date: 3 Nov 2015

Languages, Certificate CEFR level C1 (Academic English), Ghent University

Award Date: 14 Sep 2013

Medical Sciences, PhD, Vrije Universiteit Brussel

Award Date: 7 Jul 2004

Biomedical Sciences, Master, Vrije Universiteit Brussel

Award Date: 3 Jul 1998


Dive into the research topics where Karine Breckpot is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or